Phi X 174 Virus Reduction

Authors
Park Seo-Hyun and Jeon, Yong- Woo, Technical Manager
Facility
Korea Testing Laboratory
Download
Full Report

Objective

To assess the performance of the Defend 1050 in reducing phi X 174 virus a surrogate for Hepatitis B23, Hepatitis C23 and HIV2.

Methodology

  • Test Method: KOUVA AS02: 2019
  • Virus: Phi-X174 (ATCC 13706-B1)
  • Temperature: (23 +/- 2) °C
  • Humidity: (50 +/- 5) % R.H.
  • Test time: 30 minutes
  • Test chamber: 60m3
  • Air flow: Maximum

Summary of Results

The Defend 1050 achieved a 98.8% reduction of phi X 174 virus in 30 minutes in a 60m3 chamber.

Subscribe to our newsletter

Get news and updates about our latest products and offerings

Social

Partners